Oncotarget

Research Papers:

Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1

Kamil Andrzej Lipinski _, Christian Britschgi, Karen Schrader, Yann Christinat, Lukas Frischknecht and Wilhelm Krek

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:29635-29647. https://doi.org/10.18632/oncotarget.8816

Metrics: PDF 854 views  |   HTML 1343 views  |   ?  


Abstract

Kamil Andrzej Lipinski*,1, Christian Britschgi*,1, Karen Schrader*,1, Yann Christinat1, Lukas Frischknecht1, Wilhelm Krek1

1Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland

*These authors have contributed equally to this work

Correspondence to:

Wilhelm Krek, e-mail: wilhelm.krek@biol.ethz.ch

Keywords: URI1, prefoldin, p53, chaperone dependency, colorectal cancer

Received: October 24, 2015    Accepted: March 28, 2016    Published: April 18, 2016

ABSTRACT

Chaperone dependency of cancer cells is an emerging trait that relates to the need of transformed cells to cope with the various stresses associated with the malignant state. URI1 (unconventional prefoldin RPB5 interactor 1) encodes a member of the prefoldin (PFD) family of molecular chaperones that acts as part of a heterohexameric PFD complex, the URI1 complex (URI1C), to promote assembly of multiprotein complexes involved in cell signaling and transcription processes. Here, we report that human colorectal cancer (CRCs) cell lines demonstrate differential dependency on URI1 and on the URI1 partner PFD STAP1 for survival, suggesting that this differential vulnerability of CRC cells is directly linked to URI1C chaperone function. Interestingly, in URI1-dependent CRC cells, URI1 deficiency is associated with non-genotoxic p53 activation and p53-dependent apoptosis. URI1-independent CRC cells do not exhibit such effects even in the context of wildtype p53. Lastly, in tumor xenografts, the conditional depletion of URI1 in URI1-dependent CRC cells was, after tumor establishment, associated with severe inhibition of subsequent tumor growth and activation of p53 target genes. Thus, a subset of CRC cells has acquired a dependency on the URI1 chaperone system for survival, providing an example of ‘non-oncogene addiction’ and vulnerability for therapeutic targeting.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 8816